1-3 of 3
Guadalupe Rodriguez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

Emanuele Angelucci, MD, Junmin Li, Peter L Greenberg, MD, Wu Depei, MD, PhD, Ming Hou, MD, Efreen Montaño Figueroa, PhD, Guadalupe Rodriguez, Xunwei Dong, Jagannath Ghosh, Orna Bornstein, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 234.
https://doi.org/10.1182/blood-2018-99-111134
Published: 2018
Journal Articles

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Michelle Ann Soriano, PhD, Roberto Ovilla, MD, Maria Guadalupe Rodríguez-González, MD, Renée Arnold, PharmD, RPh, Dalia Mahmoud, MBA
Journal: Blood
Blood (2013) 122 (21): 5593.
https://doi.org/10.1182/blood.V122.21.5593.5593
Published: 2013
Journal Articles

Cytogenetics As a Prognostic Factor Of The Overall Survival (OS) Of Mexican Patients With Myelodysplastic Syndrome (MDS)

Maria Guadalupe Rodriguez-Gonzalez, MD, Yaneth Martinez-Ibarra, MD, Jorge Vela-Ojeda, MD, PhD, Kevin Nacho-Vargas, MD, Luis Meillon, MD, Yamile Fattel, MD, Julio Robledo, MD, MSc, Tonatiuh Romero-Salas, PhD, Moises Xolotl-Castillo, MD
Journal: Blood
Blood (2013) 122 (21): 5236.
https://doi.org/10.1182/blood.V122.21.5236.5236
Published: 2013